全文获取类型
收费全文 | 63773篇 |
免费 | 5553篇 |
国内免费 | 4403篇 |
专业分类
耳鼻咽喉 | 391篇 |
儿科学 | 1777篇 |
妇产科学 | 848篇 |
基础医学 | 12021篇 |
口腔科学 | 1301篇 |
临床医学 | 5666篇 |
内科学 | 9724篇 |
皮肤病学 | 932篇 |
神经病学 | 3956篇 |
特种医学 | 1377篇 |
外国民族医学 | 31篇 |
外科学 | 3338篇 |
综合类 | 13749篇 |
现状与发展 | 25篇 |
一般理论 | 1篇 |
预防医学 | 3248篇 |
眼科学 | 1142篇 |
药学 | 5007篇 |
6篇 | |
中国医学 | 1438篇 |
肿瘤学 | 7751篇 |
出版年
2024年 | 47篇 |
2023年 | 615篇 |
2022年 | 982篇 |
2021年 | 1801篇 |
2020年 | 1719篇 |
2019年 | 1648篇 |
2018年 | 1568篇 |
2017年 | 1771篇 |
2016年 | 2071篇 |
2015年 | 2105篇 |
2014年 | 3222篇 |
2013年 | 4307篇 |
2012年 | 3504篇 |
2011年 | 4276篇 |
2010年 | 3483篇 |
2009年 | 3542篇 |
2008年 | 3812篇 |
2007年 | 4189篇 |
2006年 | 4044篇 |
2005年 | 3779篇 |
2004年 | 3430篇 |
2003年 | 2981篇 |
2002年 | 2635篇 |
2001年 | 2404篇 |
2000年 | 1965篇 |
1999年 | 1614篇 |
1998年 | 1293篇 |
1997年 | 1046篇 |
1996年 | 759篇 |
1995年 | 777篇 |
1994年 | 574篇 |
1993年 | 394篇 |
1992年 | 299篇 |
1991年 | 238篇 |
1990年 | 210篇 |
1989年 | 138篇 |
1988年 | 97篇 |
1987年 | 71篇 |
1986年 | 56篇 |
1985年 | 85篇 |
1984年 | 48篇 |
1983年 | 21篇 |
1982年 | 35篇 |
1981年 | 26篇 |
1980年 | 15篇 |
1979年 | 12篇 |
1978年 | 6篇 |
1977年 | 6篇 |
1976年 | 3篇 |
1975年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
52.
53.
54.
55.
[摘要]?目前研究已知HBV有多种基因型,不同基因型在不同的种族、地域方面分布特点不同且HBV基因型是造成慢性感染自然史差异的原因之一,它们在感染的临床表现和抗病毒治疗的反应中起着重要作用。检测HBV基因型和了解HBV不同基因型对疾病预后的影响,对评估患者疾病结局和指导临床规划最佳治疗方案具有重要意义。
[关键词] 乙型肝炎病毒;基因型;基因突变;治疗 相似文献
56.
57.
58.
《中医科学杂志(英文)》2022,9(2):166-180
ObjectiveTo observe the relationship between the different stages of type 2 diabetes mellitus (T2DM) and the intestinal flora and verify its underlying mechanism.MethodsT2DM rats were generated by high-fat diet (HFD) combined with intraperitoneal streptozotocin (STZ) injection. The rats were divided into four groups: the control group (fed with normal feed for 1 month), the HFD group (fed with HFD for 1 month), the T2DM group (HFD combined with STZ and blood glucose ≥11.1 mM), and the unformed T2DM model (Un-mod) group (HFD combined with STZ and blood glucose <11.1 mM). Feces were collected, and bacterial communities in the fecal samples were analyzed by 16S rRNA gene sequencing. The content of short-chain fatty acids (SCFAs) in feces was measured by gas chromatography. Western blot and quantitative real-time polymerase chain reaction were used to detect the expression of G protein-coupled receptor 41 (GPR41) and GPR43.ResultsAt different stages of T2DM, the intestinal flora and SCFAs content of rats were significantly decreased (all P < .05). Our results indicated that g__Prevotella had a significant negative correlation, and g__Ruminococcus_torques_group and g__lachnoclastic had a significant positive correlation with blood glucose. The content of SCFAs, in particular acetate and butyrate, in rat feces of different stages of T2DM were significantly reduced, as well as GPR41 and GPR43 expression. The results in the Un-mod group were similar to the T2DM group, and the expression of GPR41 and GPR43 proteins were significantly higher than those in the T2DM group (both P < .001).ConclusionThe intestinal flora–SCFAs–GPR41/GPR43 network may be important in the development of T2DM. Decreasing blood glucose levels by regulating the intestinal flora may become a new therapeutic strategy for T2DM, which has very important clinical and social values. 相似文献
59.
60.
John Nicolette Joel Murray Paul Sonders Alison Kondratiuk Meredith Crosby 《Environmental and molecular mutagenesis》2021,62(1):4-17
Hydrazine has been described as a mutagenic, probable human carcinogen. It is mutagenic in in vitro systems such as bacterial reverse mutation (Ames) tests and some yeast systems, as well as in in vivo systems with drosophila. It was shown to cause chromosome damage both in vitro and in vivo but was negative in some well‐validated mammalian mutation systems such as CHO HPRT assays. Importantly, there is only one in vivo gene mutation test reported, which was negative. Our objective was to determine if hydrazine is mutagenic in mammalian test systems. Thus, we conducted an in vitro gene mutation test in Muta?Mouse lung epithelial cells (FE1 cell assay) and a regulatory‐compliant in vivo Big Blue® mouse test. Consistent with previous reports, an additional six‐well Ames assay showed that hydrazine was mutagenic to bacteria. The FE1 cell assay was negative in conditions with and without metabolic activation when tested to cytotoxicity limits. In the Big Blue® mouse study, female mice received dosages of hydrazine up to 10.9 mg/kg via drinking water for 28 days. This dose is comparable to a dose used in a carcinogenicity study where female mice had significant increases in hepatocellular adenoma at 11.5 mg/kg. There were no increases in mutant frequency in liver and lung, two tissues sensitive to the carcinogenic effects of hydrazine in mice. Our research shows that hydrazine is not mutagenic in mammalian cells either in vitro or in vivo, indicating mutagenicity may not play a role in the carcinogenicity of hydrazine. 相似文献